Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials
glecirasib治疗KRAS G12C突变实体瘤的疗效和安全性:两项I/II期试验的汇总分析
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.70056
Li, Jian; Deng, Ting; Gu, Yanhong; Calles Blanco, Antonio; Li, Zhihua; Bai, Chunmei; Wu, Lin; Huang, Jing; Li, Xingya; Yao, Yu; Song, Zhengbo; Li, Yongsheng; Liu, Lian; Xing, Ligang; Wu, Wenming; Martínez-Pérez, Julia; Hubert, Ayala; Zugazagoitia, Jon; Zhang, Jian; Wang, Yongsheng; Zhao, Yanqiu; Wen, Guilan; Xia, Guohao; Zhong, Diansheng; Chen, Xueqin; Jiang, Kuirong; Wang-Gillam, Andrea; Ding, Yuli; Liu, Sumei; Rao, Zhiyue; Liu, Xinghu; Shen, Lin